The launch of AlbuFree™ DX underscores Dyadic’s strategy to prioritize recombinant protein products that have clear commercial pathways and are supported by well-established end markets. Under the ...

The appropriateness of albumin use and baseline albumin usage patterns were studied. Institutional practice patterns regarding the use of albumin were compared to criteria established by an ...

New York, United States, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The Global Albumin Market Size is to Grow from USD 6.1 Billion in 2022 to USD 9.6 Billion by 2032, at a Compound Annual Growth Rate (CAGR) of ...

The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Early mortality is a substantial problem in AML. The results suggest that ...

Albumin has been identified as a powerful natural defense against mucormycosis, with low levels signaling heightened risk and a potential opportunity for new preventive therapies. An international ...

These days, in the outpatient clinics of university hospital gastroenterology departments treating liver disease patients, doctors say that out of ten patients, six or so ask, “Should I eat albumin?” ...

This page lists all known medications that could potentially lead to 'Increase in Blood Albumin' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Please provide your email address to receive an email when new articles are posted on . Using albumin as a protein supplement in artificial tear solutions may provide an option to treat ocular surface ...

Novozymes Biopharma, part of Novozymes A/S world leader in bioinnovation, today announced that an ophthalmic solution made using its recombinant human albumin, has been approved for Phase I/II ...

Please provide your email address to receive an email when new articles are posted on . Researchers identified a correlation between eGFR and urine albumin-creatinine ratio with structural brain ...